Updated guidelines recommend improving access to specialised stroke units and thrombolytic therapy, and the rapid assessment of patients with transient ischaemic attacks for stroke risk
Stroke, with its high incidence and serious consequences, is one of the foremost health challenges for Australia and globally. Although stroke rates appear to be decreasing,1 population ageing will intensify the impact of this disease and the need for effective prevention and management strategies.2 Stroke is a complex disease with a range of causes, manifestations, outcomes and treatment approaches, but is too common and costly to be left as the province of a single clinical discipline, neurology. As the therapeutic time window in which to rescue or “protect” the brain from ischaemic damage is extremely short, there is a need for good systems of communication and responsive, expert team care, both in the community and in hospitals, to ensure safe and effective delivery of interventions early after onset and in subsequent phases of acute stroke. Indeed, the single most important therapeutic advance in stroke medicine is arguably the recognition that well coordinated, multidisciplinary care in the form of stroke care units (SCUs) can significantly improve the chances of recovery from stroke. So how can we improve patient access to expert SCU care and therapies that provide the best opportunity for a favourable outcome?
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Islam MS, Anderson CS, Hankey G, et al. Trends in the incidence and outcome of stroke in Perth, Western Australia, 1989 to 2001: the Perth Community Stroke Study. Stroke 2008; 39: 776-782.
- 2. Tobias M, Cheung J, Carter K, et al. Stroke surveillance: population-based estimates and projections for New Zealand. Aust N Z J Public Health 2007; 31: 520-525.
- 3. National Stroke Foundation. Clinical guidelines for acute stroke management 2007. 2nd ed. Canberra: Australian Government, National Health and Medical Research Council, 2007. http://www.strokefoundation.com.au/news/welcome/clinical-guidelines-for-acute-stroke-management (accessed Jun 2008)
- 4. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 2901-2906.
- 5. Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack and minor stroke: implications for public education and organisation of services. BMJ 2004; 328: 326-328.
- 6. Van Wijk I, Kappelle LJ, van Gijn J, et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 2005; 365: 2098-2104.
- 7. Rothwell PM, Warlow CO. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology 2005; 64: 817-820.
- 8. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007; 370: 1432-1442.
- 9. Lavallée PC, Mesenuei E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007; 6: 953-960.
- 10. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 367: 283-292.
- 11. Kehdi EE, Cordato DJ, Thomas PR, et al. Outcomes of patients with transient ischaemic attack after hospital admission or discharge from the emergency department. Med J Aust 2008; 189: 9-12.
- 12. Bray JE, Coughlan K, Bladin C. Thrombolytic therapy for acute ischaemic stroke: a successful implementation in an Australian tertiary hospital. Intern Med J 2006; 36: 483-488.
- 13. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet 2003; 362: 1225-1230.
- 14. National Health Priority Action Council. National Service Improvement Framework for Heart, Stroke and Vascular Disease. Canberra: Australian Government Department of Health and Ageing, 2006.
I have accepted research grants, honoraria and speaker fees from Boehringer Ingelheim and I am employed by the George Institute and the NHMRC to conduct research on stroke.